A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases
Clinical trial NCT05755035 · COMPLETED
Trial details
- NCT number
- NCT05755035
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-24
- Primary completion
- 2026-01-20
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.